Ligand validation:8QMZ

W6O: (3~{a}~{R},6~{a}~{S})-~{N}-[(2,4-dichlorophenyl)methyl]-2-(4-methylphenyl)sulfonyl-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-5-carboxamide

W6O is a Ligand Of Interest in 8QMZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8QMZ_W6O_A_601	57%	22%	0.124	0.899	0.66	2.52	-	8	0	0	100%	1
8QMZ_W6O_B_601	57%	26%	0.128	0.903	0.8	2.16	2	9	0	0	100%	1
8QMZ_W6O_C_601	57%	24%	0.131	0.906	0.65	2.4	-	10	0	0	100%	1
8QMZ_W6O_D_601	47%	26%	0.147	0.887	0.72	2.24	1	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.